Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

By Jason Bailey Sign up for our Watching newsletter to get recommendations on the best films and TV shows to stream and watch, delivered to your inbox. The sheer volume of films on Netflix — and ...